Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.
Dr Nour Abahadra of Memorial Sloan Kettering discusses the diagnosis, treatment, and management of metastatic triple negative breast cancer (TNBC). Patient guest, Shay Elkins, shares her experience, from discovering a rapidly growing tumor to navigating her diagnosis and treatment, highlighting the importance of personalized support and resources available online.